Das P - Search Results

1

Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition.

Chakrabarty P, Jansen-West K, Beccard A, Ceballos-Diaz C, Levites Y, Verbeeck C, Zubair AC, Dickson D, Golde TE, Das P. Chakrabarty P, et al. Among authors: das p. FASEB J. 2010 Feb;24(2):548-59. doi: 10.1096/fj.09-141754. Epub 2009 Oct 13. FASEB J. 2010. PMID: 19825975 Free PMC article.

2

Open peer commentary regarding Abeta immunization and CNS inflammation by Pasinetti et al.

Das P, Golde TE. Das P, et al. Neurobiol Aging. 2002 Sep-Oct;23(5):671-4; discussion 683-4. doi: 10.1016/s0197-4580(02)00031-3. Neurobiol Aging. 2002. PMID: 12392769 Review. No abstract available.

3

Overexpression of nicastrin increases Abeta production.

Murphy MP, Das P, Nyborg AC, Rochette MJ, Dodson MW, Loosbrock NM, Souder TM, McLendon C, Merit SL, Piper SC, Jansen KR, Golde TE. Murphy MP, et al. Among authors: das p. FASEB J. 2003 Jun;17(9):1138-40. doi: 10.1096/fj.02-1050fje. Epub 2003 Apr 8. FASEB J. 2003. PMID: 12692078

4

Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.

Das P, Howard V, Loosbrock N, Dickson D, Murphy MP, Golde TE. Das P, et al. J Neurosci. 2003 Sep 17;23(24):8532-8. doi: 10.1523/JNEUROSCI.23-24-08532.2003. J Neurosci. 2003. PMID: 13679422 Free PMC article.

5

Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.

Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE. Levites Y, et al. Among authors: das p. J Clin Invest. 2006 Jan;116(1):193-201. doi: 10.1172/JCI25410. Epub 2005 Dec 8. J Clin Invest. 2006. PMID: 16341263 Free PMC article.

6

Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy.

Das P, Smithson LA, Price RW, Holloway VM, Levites Y, Chakrabarty P, Golde TE. Das P, et al. J Neuroinflammation. 2006 Jul 26;3:17. doi: 10.1186/1742-2094-3-17. J Neuroinflammation. 2006. PMID: 16872492 Free PMC article.

7

Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models.

Levites Y, Smithson LA, Price RW, Dakin RS, Yuan B, Sierks MR, Kim J, McGowan E, Reed DK, Rosenberry TL, Das P, Golde TE. Levites Y, et al. Among authors: das p. FASEB J. 2006 Dec;20(14):2576-8. doi: 10.1096/fj.06-6463fje. Epub 2006 Oct 26. FASEB J. 2006. PMID: 17068112

8

Dysfunction of TGF-beta signaling in Alzheimer's disease.

Das P, Golde T. Das P, et al. J Clin Invest. 2006 Nov;116(11):2855-7. doi: 10.1172/JCI30284. J Clin Invest. 2006. PMID: 17080189 Free PMC article.

9

Quantitative and mechanistic studies of Abeta immunotherapy.

Golde TE, Das P, Levites Y. Golde TE, et al. Among authors: das p. CNS Neurol Disord Drug Targets. 2009 Mar;8(1):31-49. doi: 10.2174/187152709787601830. CNS Neurol Disord Drug Targets. 2009. PMID: 19275635 Review.

10

IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice.

Chakrabarty P, Ceballos-Diaz C, Beccard A, Janus C, Dickson D, Golde TE, Das P. Chakrabarty P, et al. Among authors: das p. J Immunol. 2010 May 1;184(9):5333-43. doi: 10.4049/jimmunol.0903382. Epub 2010 Apr 5. J Immunol. 2010. PMID: 20368278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,329 results

Search Page